We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
Cap. Flow
-$587M
Cap. Flow %
-4.35%
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38

Top Buys

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$30.1M
2
ET icon
Energy Transfer Partners
ET
+$24.7M
3
FLJP icon
Franklin FTSE Japan ETF
FLJP
+$11.8M
4
WFC icon
Wells Fargo
WFC
+$9.66M
5
ALKS icon
Alkermes
ALKS
+$8.97M

Top Sells

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$49.8M
2
EPD icon
Enterprise Products Partners
EPD
+$49.1M
3
WES icon
Western Midstream Partners
WES
+$44.8M
4
BPL
Buckeye Partners, L.P.
BPL
+$42.5M
5
EQM
EQM Midstream Partners, LP
EQM
+$28.6M

Sector Composition

Rank Sector Weight
1 Energy 65.41%
2 Financials 7.05%
3 Healthcare 3.6%
4 Consumer Discretionary 3.1%
5 Technology 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMC
876
Summit Midstream
SMC
$421M
$83K ﹤0.01%
744
+27
+4% +$3.29K
ABEO icon
877
Abeona Therapeutics
ABEO
$345M
– –
-4,632
Closed -$852K
ABUS icon
878
Arbutus Biopharma
ABUS
$865M
– –
-134,053
Closed -$480K
AKBA icon
879
Akebia Therapeutics
AKBA
$327M
– –
-282,329
Closed -$2.31M
ASND icon
880
Ascendis Pharma A/S
ASND
$16.7B
– –
-70,468
Closed -$8.29M
ATRA icon
881
Atara Biotherapeutics
ATRA
$71.2M
– –
-4,410
Closed -$4.38M
BAK icon
882
Braskem
BAK
$980M
– –
-22,764
Closed -$588K
CASI
883
DELISTED
CASI Pharmaceuticals
CASI
– –
-23,015
Closed -$661K
CPRX
884
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-248,154
Closed -$1.27M
CRSP icon
885
CRISPR Therapeutics
CRSP
$4.58B
– –
-125,116
Closed -$4.47M
FBRX icon
886
Forte Biosciences
FBRX
$1.12B
– –
-148
Closed -$603K
LKFT
887
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
– –
-87,116
Closed -$10.3M
GNW icon
888
Genworth Financial
GNW
$3.8B
– –
-15,317
Closed -$59K
GPRE icon
889
Green Plains
GPRE
$1.19B
– –
-31,421
Closed -$524K
GRPN icon
890
Groupon
GRPN
$980M
– –
-1,197
Closed -$85K
HIW icon
891
Highwoods Properties
HIW
$3.71B
– –
-5,798
Closed -$271K
INSM icon
892
Insmed
INSM
$23.2B
– –
-187,286
Closed -$5.44M
LTC
893
LTC Properties
LTC
$2.16B
– –
-40,394
Closed -$1.85M
LITS
894
Lite Strategy Inc
LITS
$33.6M
– –
-8,593
Closed -$528K
NOK icon
895
Nokia
NOK
$50.8B
– –
-12,639
Closed -$72K
NPK icon
896
National Presto Industries
NPK
$891M
– –
-5,825
Closed -$632K
ODP
897
DELISTED
ODP
ODP
– –
-3,274
Closed -$119K
PAAS icon
898
Pan American Silver
PAAS
$18.6B
– –
-398,874
Closed -$5.29M
SAIC icon
899
Saic
SAIC
$5.03B
– –
-10,157
Closed -$782K
SIRI icon
900
SiriusXM
SIRI
$10B
– –
-1,244
Closed -$71K
33 34 35
36
37

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.

  • ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
  • ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
  • ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
  • ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
  • ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
  • ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
  • ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.